TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 56 filers reported holding TOKAI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | – | 17 | +6.2% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 16 | -93.8% | 0.00% | – |
| Q1 2016 | $1,000 | – | 260 | +584.2% | 0.00% | – |
| Q4 2015 | $0 | – | 38 | +137.5% | 0.00% | – |
| Q3 2015 | $0 | – | 16 | -30.4% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 23 | -99.7% | 0.00% | – |
| Q4 2014 | $118,000 | -2.5% | 8,000 | 0.0% | 0.00% | – |
| Q3 2014 | $121,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Owl Capital Management, LLC | 130,000 | $1,729,000 | 1.23% |
| Novo Holdings A/S | 1,238,252 | $16,469,000 | 1.18% |
| Perceptive Advisors | 485,338 | $6,455,000 | 0.39% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 740,978 | $9,855,000 | 0.38% |
| Tourbillon Capital Partners, L.P. | 517,000 | $6,876,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 128,041 | $1,703,000 | 0.06% |
| Alyeska Investment Group, L.P. | 613,134 | $8,154,000 | 0.05% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $80,000 | 0.04% |
| OPPENHEIMER & CO INC | 12,048 | $160,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 10,000 | $133,000 | 0.00% |